Competitive and non-competitive inhibition of L-3,4-dihydroxyphenylalanine uptake in Opossum kidney cells

European Journal of Pharmacology

Volumn 332, Issue 2, 1997, Pages 219-225

  Gomes, Pedro ^a   Serrão, Maria Paula ^a   Vieira Coelho, Maria Augusta ^a   Soares da Silva, Patrício ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Cell transport; Cyanine derivative; L 5 HTP (L 5 hydroxytryptophan); L DOPA (L 3,4 dihydroxyphenylalanine); OK (Opposum kidney) cell

Indexed keywords

5 HYDROXYTRYPTOPHAN; CYANINE DYE; LEVODOPA; PARGYLINE; TOLCAPONE;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG UPTAKE; KIDNEY CELL; KINETICS; NONHUMAN; OPOSSUM; PRIORITY JOURNAL;

ANIMALS; BINDING, COMPETITIVE; CARBOCYANINES; CELLS, CULTURED; COLORING AGENTS; KIDNEY; KINETICS; LEVODOPA; OPOSSUMS; QUINOLINIUM COMPOUNDS; SEROTONIN;

EID: 0030804935     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01083-2     Document Type: Article

References (29)

1. Baines, A.D., Chan, W., 1980. Production of urine free dopamine from dopa: A micropuncture study. Life Sci. 26, 253-259.
2. Bradford, M.M., 1976. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Cha, S., 1975. Tight binding inhibitors. I. Kinetic behavior. Biochem. Pharmacol. 24, 2177-2185.
4. Chan, Y.L., 1976. Cellular mechanisms of renal tubular transport of L-DOPA and its derivatives in the rat: Microperfusions studies. J. Pharmacol. Exp. Ther. 199, 17-24.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
6. Glahn, R.P., Onsgard, M.J., Tyce, G.M., Chinnow, S.L., Knox, F.G., Dousa, T.P., 1993. Autocrine/paracrine regulation of renal Na(+)-phosphate cotransport by dopamine. Am. J. Physiol. 264, F618-F622.
7. Goldstein, D.S., Stull, R., Eisenhofer, G., Gill, J. Jr., 1989. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin. Sci. 76, 517-522.
8. Guimarães, J.T., Vieira-Coelho, M.A., Serrão, M.P., Soares-da-Silva, P., 1997. Opossum kidney (OK) cells in culture synthesise and degrade the natriuretic hormone dopamine: A comparison with rat renal tubular cells. Int. J. Biochem. Cell Biol. 29, 681-688.
9. Hagege, J., Richet, G., 1985. Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int. 27, 3-8.
10. Hayashi, M., Yamaji, Y., Kitajima, W., Saruta, T., 1990. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am. J. Physiol. 258, F28-F33.
11. Kuchel, O., Shigetomi, S., 1992. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients. Hypertension 19, 634-638.
12. Lee, M.R., 1993. Dopamine and the kidney: Ten years on. Clin. Sci. 84, 357-375.
13. 2. Naunyn-Schmiedebergs Arch. Pharmacol. 350, 130-142.
14. Motulsky, H.J., Spannard, P., Neubig, R., 1994. GraphPad Prism (version 1.0). GraphPad Prism Software, San Diego, CA.
15. Nash, S.R., Godinot, N., Caron, M.G., 1993. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: Expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Mol. Pharmacol. 44, 918-925.
16. Perrichot, R., Garciaocana, A., Couette, S., Comoy, E., Amiel, C., Friedlander, G., 1995. Locally formed dopamine modulates renal Na-P-I co-transport through Da(1) and Da(2) receptors. Biochem. J. 312, 433-437.
17. Pinto-do-O, P.C., Soares-da-Silva, P., 1996. Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br. J. Pharmacol. 118, 741-747.
18. Rennick, B.R., Kandel, A., Peters, L., 1956. Inhibition of the renal tubular excretion of tetraethylammonium and N′-methylnicotinamide by basic cyanine dyes. J. Pharmacol. Exp. Ther. 118, 204-219.
19. Russ, H., Gliese, M., Sonna, J., Schhomig, E., 1992. The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+). Naunyn-Schmiedebergs Arch. Pharmacol. 346, 158-165.
20. Russ, H., Sonna, J., Keppler, K., Baunach, S., Schömig, E., 1993. Cyanine-related compounds: A novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedebergs Arch. Pharmacol. 348, 458-465.
21. Sakamoto, T., Chen, C., Lokhandwala, M.F., 1994. Lack of renal dopamine production during acute volume expansion in Dahl salt-sensitive rats. Clin. Exp. Hypertens. 16, 197-206.
22. Shigetomi, S., Buu, N.T., Kuchel, O., 1991. Dopaminergic abnormalities in borderline essential hypertensive patients. Hypertension 17, 997-1002.
23. Shikuma, R., Yoshimura, M., Kambara, S., Yamazaki, H., Takashina, R., Takahashi, H., Takeda, K., Ijichi, H., 1986. Dopaminergic modulation of salt sensitivity in patients with essential hypertension. Life Sci. 38, 915-921.
24. Soares-da-Silva, P., 1994. Source and handling of renal dopamine: Its physiological importance. News Physiol. Sci. 9, 128-134.
25. Soares-da-Silva, P., Fernandes, M.H., 1990. Regulation of dopamine synthesis in the rat kidney. J. Auton. Pharmacol. 10, s25-s30.
26. Soares-da-Silva, P., Fernandes, M.H., Pinto-do-O, P.C., 1994. Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br. J. Pharmacol. 112, 611-615.
27. Soares-da-Silva, P., Pinto-do-O, P.C., 1996. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: Effects of amine precursors on the cell inward transfer and decarboxylation. Br. J. Pharmacol. 117, 1187-1192.
28. Soares-da-Silva, P., Serrão, M.P., Vieira-Coelho, M.P., 1996. A comparative study on the synthesis of the natriuretic hormone dopamine in OK and LLC-PK1 cells. Cell. Biol. Int. 20, 539-544.
29. Zimlichman, R., Levinson, P.D., Kelly, G., Stull, R., Keiser, H.R., Goldstein, D.S., 1988. Derivation of urinary dopamine from plasma dopa. Clin. Sci. 75, 515-520.